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Boric acidAbstract Aluminium phosphide (AlP) is a storage fumigant pesticide, which is used to protect
stored grains especially from insects and rodents. It releases phosphine (PH3) gas, a highly toxic
mitochondrial poison, in contact with moisture, particularly if acidic. Although the exact mecha-
nism of action is unknown so far, the major mechanism of PH3 toxicity seems to be the inhibition
of cytochrome-c oxidase and oxidative phosphorylation which eventually results in adenosine tri-
phosphate (ATP) depletion and cell death. Death due to AlP poisoning seems to be as a result
of myocardial damage. No efﬁcient antidote has been found for AlP poisoning so far, and unfor-
tunately, most of the poisoned human cases die. PH3, like ammonia (NH3), is a Lewis base with a
lone-pair electron. However, boric acid (B(OH)3) is a Lewis acid with an empty p orbital. It is pre-
dicted that lone-pair electron from PH3 is shared with the empty p orbital from B(OH)3 and a com-
pound forms in which boron attains its octet. In other words, PH3 is trapped and neutralised by
B(OH)3. The resulting polar reaction product seems to be excretable by the body due to hydrogen
bonding with water molecules. The present article proposes boric acid as a non-toxic and efﬁcient
trapping agent and an antidote for PH3 poisoning by investigating the chemical reaction between
them.
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Aluminium phosphide (AlP) as a pesticide is present in the
forms of tablet, dust, pellet and grains [1]. In Iran, the tablet
form of AlP is called ‘rice tablet’ because it is used for protec-
tion of rice [2]. It reacts with moisture and water and produces
phosphine gas (PH3) [3], a colourless, ﬂammable and highly
toxic gas, with an odour of garlic or decaying ﬁsh [4]. Thus,
it is called a fumigant pesticide [5]. AlP is not toxic per se
but the toxic gas PH3, which is formed in contact to moisture,
is responsible for toxicity of AlP [6]. Although the exact mech-
anism of action is unknown so far, the major mechanism of
PH3 toxicity seems to be the inhibition of cytochrome-c oxi-
dase and oxidative phosphorylation [7], which eventually re-
sults in adenosine triphosphate (ATP) depletion and cell
death [4]. AlP is a multi-organ poison. It has toxic effects on
cardiovascular, respiratory, hepatic and gastrointestinal sys-
tems and induces acid–base disturbances [7]. Death due to
PH3 poisoning seems to be as a result of myocardial damage
and cardiovascular collapse [8]. Unfortunately, no speciﬁc
antidote has been found for routine treatment of AlP poison-
ing so far and most of the poisoned human cases die [7].
Boric acid (B(OH)3) is a colourless, odourless, transparent
material with a slightly unctuous touch [9]. It has a water sol-
ubility of about 50 g l1 (21 C). The pH value of a 0.1 M solu-
tion of boric acid is 5.1; thus, it is considered as a weak acid
[10]. Boric acid is considered as a non-toxic material with a
5.14 g kg1 oral median lethal dose (LD50) in rats [11].
Boric acid with an empty p orbital is considered as a Lewis
acid (electron acceptor), which theoretically can react with a
Lewis base (electron donor). A Lewis base has a lone-pair elec-
tron that can be shared with empty p orbital of B(OH)3. Boron
attains its octet in the resulting compound [12].
In the present study, the possibility of a reaction between a
non-toxic Lewis acid (boric acid) and a highly toxic Lewis base
(PH3) has been investigated and thus a new antidote for PH3 is
proposed.
Hypotheses/ideas
Reaction between boron triﬂouride (BF3) and ammonia (NH3)
has been well described long time ago [13–15]. In this reaction,
NH3 as a Lewis base shares its lone-pair electron with an
empty p orbital of a Lewis acid (BF3). Thus, NH3 acts as an
electron donor and BF3 acts as an electron acceptor. After
reaction, the B–N bond has been shown to have a covalent
bond characteristic [13–15]. A similar reaction between
B(OH)3 (Lewis acid) and PH3 (Lewis base) is theoretically ex-
pected. It is predicted that boric acid as a non-toxic weak Le-
wis acid chemically bonds with highly toxic phosphine gas. In
this reaction, phosphine gas is trapped and neutralised by bo-
ric acid. The resulting polar reaction product seems to be
excretable by the body due to hydrogen bonding with water
molecules. Thus, boric acid is proposed as a possible efﬁcient
non-toxic antidote for phosphine gas poisoning.
Evaluation of hypotheses/ideas
To evaluate the effectiveness of boric acid to trap and neutral-
ise phosphine gas, the chemical reaction between these twosubstances should be ﬁrst studied. The volume of released
phosphine gas and the rate of phosphine gas release in boric
acid solution are determined and compared (at the same pres-
sure and temperature) with the condition where boric acid is
replaced with water (control). The pH of the reaction media
will be monitored continuously to evaluate the increase in
pH because PH3 is a base. Addition of hydrochloric acid to bo-
ric acid solution and reaching the solution pH to 2 (approxi-
mate pH of the stomach) and determination of the volume
of released phosphine gas and the rate of phosphine gas release
will reveal the efﬁciency of boric acid in trapping and neutral-
ising phosphine in the stomach. Released phosphine will be
collected in and its volume measured by an upside-down
water-ﬁlled glass measuring cylinder in a water basin. Rate
of phosphine gas release will be determined by measuring the
produced phosphine gas at appropriate time intervals. To con-
ﬁrm the reaction between boric acid and phosphine gas and
formation of a P–B bond, infrared spectroscopy will be used
using a sodium chloride (NaCl) cell.
Discussion/conclusion
Although digoxin [16], N-acetylcysteine [17], hyperbaric oxy-
gen [18], 25Mg2+-carrying nanoparticles [7], intragastric irriga-
tion with sweet almond oil [19], combination of vitamin C and
methylene blue [20], extensive gastric lavage with coconut oil
and sodium bicarbonate solution with simultaneous aspiration
[21], intra-aortic balloon pump [22], N-omega-nitro-L-arginine
methyl ester (L-NAME) [17], combination of atropine and
pralidoxime [23] and trimetazidine [24] have been reported efﬁ-
cient either experimentally or in case reports, unfortunately, no
speciﬁc antidote has been found for routine treatment of AlP
poisoning so far and most poisoned human cases do not sur-
vive [7].
The reaction between BF3 as a Lewis acid and NH3 as a Le-
wis base is schematically depicted in Fig. 1(a). In this reaction,
ammonia and boron triﬂouride act as an electron donor and
electron acceptor, respectively. The resulting reaction product
is polar with hydrogen bonding with water molecules [12–15].
The reaction between boric acid (B(OH)3 as a Lewis acid
and PH3 as a Lewis base is comparable with the reaction be-
tween BF3 and NH3 (Fig. 1(b)). It is predicted that the product
of this reaction is a polar adduct with hydrogen bonding with
water molecules.
Unlike BF3 which is a toxic substance and cannot be used
medically, boric acid is a non-toxic weak Lewis acid [11], which
has several medical uses such as antiseptic, insecticide, eyewash
solution and etc [25]. Although many studies reviewed boric
acid toxicity in humans, most of them have focussed on infants
and children who are inherently susceptible to xenobiotics [26–
33]. A review of acute human exposure to boric acid indicated
that the effects of any particular dose can vary dramatically
among individuals. The average dose for asymptomatic inges-
tion cases, which accounts for 88% of all ingestions, is around
0.9 g. However, the range of reported asymptomatic doses is
wide, from 0.01 to 88.8 g. The average dose causing symptoms
was 3.2 g, but it was also highly variable with individual values
ranging from 0.1 to 55.5 g. Further, minimum oral lethal doses
of boric acid in humans have been estimated from accidental
poisonings to be in the range of 5–20 g for adults, 3–6 g for
children and <5 g for infants [34].
Figure 1 Chemical reaction between boron triﬂuoride and ammonia (a) and proposed chemical reaction between phosphine and boric
acid (b).
Proposing boric acid as an antidote for aluminium phosphide poisoning 23Boric acid does not liberate a proton in water, but rather
bonds to the O atom of an H2O molecule, which then releases
an H+ ion to form the B(OH)4 ion (with a pKa of 9.23)
according to the following chemical equation [10,12–15]:
BðOHÞ3 þH2O! BðOHÞ4 þHþ ðReaction1Þ
The pKa’s of boric acid are 9.24, 12.40 and 13.40, respec-
tively [10]. According to the Henderson–Hasselbalch equation
equation, in the acidic pH of the stomach (about 2.0), almost
all boric acid molecules exist as B(OH)3 [10] and at physiologic
pH of the human body (7.4), about 1.8% of boric acid mole-
cules exist as B(OH)4 and 1.4% of those exist as H2BO

3 .
PH3 is more basic than water; thus, it is predicted that at the
pH of stomach and of blood, a reaction between PH3 and bo-
ric acid is more probable.
It has been shown that 500 mg of a 3-g AlP tablet (which
contains about 56% pure AlP (equal to 1680 mg pure AlP))
is lethal for an adult human being [1]. According to the chem-
ical reaction of AlP with water, 1 mol (57.96 g) of AlP pro-
duces 1 mol (34 g) phosphine gas [3]:
AlPþ 3H2O! AlðOHÞ3 þ PH3 " ðReaction2Þ
Therefore, it is expected that 500 mg of a 3-g AlP tablet
(equivalent to 280 mg pure AlP) releases 164.13 mg phosphine.
One mole (34 g) of phosphine at standard pressure (1 atm) and
temperature (273.15 K or 0 C) occupies 22,400 ml volume.
Thus, it is expected that under these conditions, 164.13 mg
phosphine occupies 108.13 ml volume. It is predicted that at
normal human body temperature (310.15 K or 37 C), phos-
phine gas molecules have more energies and hence have more
toxicity than under ambient conditions [12].
According to the following chemical reaction, in the pres-
ence of hydrochloric acid of the stomach, a faster reaction oc-
curs [3]:
AlPþ 3HCl! AlCl3 þ PH3 " ðReaction3Þ
The proposed neutralisation reaction of phosphine by boric
acid is as follows:
PH3ðgÞ þ BðOHÞ3ðaqÞ ! H3P BðOHÞ3ðaqÞ ðReaction4ÞThis reaction seems to be exothermic because an aqueous
solution of an adduct with lower entropy is formed from a
gas (with higher entropy) and an aqueous solution of boric
acid.
According to reactions 2 (occurred in water), 3 (occurred at
stomach pH) and 4, it is predicted that 164.13 mg phosphine
(from 500 mg of a 3-g AlP tablet) is stoichiometrically and the-
oretically neutralised by 298.47 mg boric acid, which is very
low to poison an adult human. Therefore, the minimum efﬁ-
cient dose of boric acid for neutralisation of AlP and phos-
phine is proposed to be 1.06 times of the weight of the
former and 1.81 of that of the latter.
According to the following chemical calculation, it is pre-
dicted that an absorption peak at about 1029 cm1 due to
P–B bond stretching in the (OH)3B–PH3 adduct appears in












where m is the frequency in cm1, K is the force constant in
dynes cm1 and l is reduced mass which can be obtained by
following calculation:






where MP and MB are the atomic masses of phosphorous and
boron atoms, respectively.
The reaction of ammonia with boric acid which results in
ammonium borate is another evidence that phosphine gas
can chemically react with boric acid [36].
This article proposes boric acid as a new and efﬁcient anti-
dote for trapping and neutralising phosphine gas by investigat-
ing the chemical reaction between these two compounds.
Although the present study predicted that boric acid chemi-
cally reacts with phosphine gas, which results in more polar
and may be a more excretable product than phosphine, further
extensive chemical, in vitro and in vivo studies should be done
to show the integrity of the present study.
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First Question: What do we already know about the
subject?
There is no speciﬁc efﬁcient antidote for AlP and PH3
poisoning so far. Mortality due to AlP poisoning is very
high.
Second Question: What does your proposed theory add
to the current knowledge available, and what beneﬁts does
it have?
Boric acid is a non-toxic Lewis acid which efﬁciently
traps PH3 gas. In this reaction, boric acid acts as a Lewis
acid and phosphine acts as a Lewis base. The resulted po-
lar reaction product which has H and OH groups can
form hydrogen bonds with water molecules and hence
can be excreted in urine by the body.
Third question: Among numerous available studies, what
special further study is proposed for testing the idea?
The chemical reaction between PH3 and boric acid
should be ﬁrst studied. The volume of released PH3 gas
and rate of PH3 release in boric acid solution should be
compared (at the same pressure and temperature) with
the condition where boric acid is replaced with water
(control). In vitro and in vivo studies should also be done
to conﬁrm the present idea. Moreover, cytochrome-c oxi-
dase activity in cardiomyocytes and mortality rate should
be determined.References
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